FERRARO, Diana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.198
EU - Europa 4.312
AS - Asia 3.885
SA - Sud America 801
AF - Africa 90
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.047
GB - Regno Unito 1.684
SG - Singapore 1.301
CN - Cina 1.070
HK - Hong Kong 667
BR - Brasile 634
IT - Italia 558
DE - Germania 439
SE - Svezia 407
VN - Vietnam 289
RU - Federazione Russa 239
FI - Finlandia 217
UA - Ucraina 187
FR - Francia 130
BG - Bulgaria 123
TR - Turchia 118
ID - Indonesia 78
CA - Canada 75
KR - Corea 71
AR - Argentina 70
IN - India 56
ES - Italia 49
MX - Messico 47
AU - Australia 45
PL - Polonia 42
AT - Austria 40
NL - Olanda 39
ZA - Sudafrica 35
BD - Bangladesh 34
EC - Ecuador 31
JP - Giappone 31
IE - Irlanda 29
IQ - Iraq 26
IR - Iran 26
CZ - Repubblica Ceca 24
BE - Belgio 23
CH - Svizzera 21
MY - Malesia 20
CL - Cile 17
LT - Lituania 16
EG - Egitto 15
CO - Colombia 12
MA - Marocco 12
PY - Paraguay 12
PK - Pakistan 11
BZ - Belize 10
GE - Georgia 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
SA - Arabia Saudita 9
KE - Kenya 8
UZ - Uzbekistan 8
TN - Tunisia 7
UY - Uruguay 7
DK - Danimarca 6
IL - Israele 6
PE - Perù 6
AZ - Azerbaigian 5
NO - Norvegia 5
QA - Qatar 5
AL - Albania 4
BB - Barbados 4
DO - Repubblica Dominicana 4
GR - Grecia 4
KZ - Kazakistan 4
LB - Libano 4
NP - Nepal 4
PH - Filippine 4
RS - Serbia 4
DZ - Algeria 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
JM - Giamaica 3
JO - Giordania 3
PA - Panama 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
EU - Europa 2
GA - Gabon 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NG - Nigeria 2
PT - Portogallo 2
TH - Thailandia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
GH - Ghana 1
GY - Guiana 1
IM - Isola di Man 1
IS - Islanda 1
Totale 22.324
Salva come PNG Salva come JPEG
Città #
Fairfield 1.819
Santa Clara 1.306
Southend 1.203
Ashburn 1.174
Woodbridge 872
Singapore 765
Seattle 711
Houston 697
Hong Kong 662
Chandler 624
Cambridge 605
Wilmington 551
Ann Arbor 353
Dearborn 317
London 295
Jacksonville 290
Nyköping 284
Chicago 281
Los Angeles 193
Beijing 185
Modena 171
Hefei 163
New York 160
Helsinki 157
San Diego 142
Munich 134
Sofia 121
Princeton 120
Ho Chi Minh City 114
Salt Lake City 109
The Dalles 91
Moscow 86
Shanghai 84
Eugene 73
Hanoi 66
Jakarta 62
Dallas 59
Council Bluffs 56
Buffalo 53
São Paulo 52
Tampa 51
Elk Grove Village 50
Bremen 47
Izmir 44
Redwood City 42
Seoul 42
Norwalk 39
Phoenix 35
Boardman 33
Columbus 32
Frankfurt am Main 32
Málaga 30
Redondo Beach 30
Rio de Janeiro 30
Warsaw 30
Sterling 28
Turku 28
Vienna 27
Toronto 26
Dublin 25
Fremont 25
Guangzhou 25
Rome 25
Lancaster 24
Miami 24
Melbourne 23
Milan 23
San Jose 23
Seongnam 23
Dulles 22
Kunming 22
Hillsboro 21
Stockholm 21
Boston 20
Nuremberg 20
Atlanta 19
Edinburgh 18
Falls Church 18
Johannesburg 18
Amsterdam 17
Brussels 17
Tokyo 17
Buenos Aires 16
Paris 16
Piacenza 16
Brasília 15
Brooklyn 15
Kilburn 15
Prescot 15
Kansas City 13
Montreal 13
Olomouc 13
Orem 13
San Francisco 13
Manchester 12
Vancouver 12
Chiswick 11
Guayaquil 11
Las Vegas 11
Nanjing 11
Totale 16.667
Salva come PNG Salva come JPEG
Nome #
Definitive childlessness in women with multiple sclerosis: a multicenter study 641
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome. 413
Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis 403
Recurrent varicella following steroids and fingolimod in a Multiple Sclerosis patient 367
Isolated progressive cognitive impairment and depression in a patient with neuroradiological features suggestive of multiple sclerosis 365
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV 350
False positive absent somatosensory evoked potentials in cardiac arrest with therapeutic hypothermia. 339
iNKT cells in secondary progressive multiple sclerosis patients display pro-inflammatory profiles 339
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence 329
Paroxysmal ventricular tachicardia and pure right insular stroke 315
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: Results from an observational study 312
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 310
A quantitative comparison of BOLD fMRI responses to noxious and innocuous stimuli in the human spinal cord 304
Invariant natural killer T cells and mucosal-associated invariant T cells in multiple sclerosis 304
Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study 300
Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study 288
Acute hemichorea as unusual first multiple sclerosis presentation 281
Cerebrospinal fluid anti-Epstein-Barr virus specific oligoclonal IgM and IgG bands in patients with clinically isolated and Guillain-Barré syndrome 275
Platelet Function Testing in Patients with Acute Ischemic Stroke: An Observational Study 267
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 267
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study 266
Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients 266
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study 263
Inter-center agreement in the interpretation of oligoclonal bands 261
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM 257
Methylprednisolone-induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses 256
Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study 255
Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis 254
Mitochondrial damage-associated molecular patterns stimulate reactive oxygen species production in human microglia 250
Semiautomated segmentation of the human spine based on echoplanar images 245
Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis 243
Antiepileptic drugs in the treatment of headache: Neuroprotective effect or something else? 240
Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band‐negative patients with suspected multiple sclerosis 240
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS 238
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect? 237
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 235
Diagnostics of dysimmune peripheral neuropathies 233
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis 231
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 228
Severe anemia in a patient with multiple sclerosis treated with natalizumab 227
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 226
Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients 220
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis 219
Acute necrotizing encephalopathy: A relapsing case in a European adult [4] 218
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 216
Abnormal Circadian Modification of Aδ-Fiber Pathway Excitability in Idiopathic Restless Legs Syndrome 215
Charcot-Marie-Tooth and pain: Correlations with neurophysiological, clinical, and disability findings 214
Diagnostics of anti-MAG antibody polyneuropathy 214
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 207
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis 206
Antiepileptic drugs in the preventive treatment of migraine in children and adolescents 205
The abnormal recovery cycle of somatosensory evoked potential components in children with migraine can be reversed by topiramate 201
Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: A laser-evoked potential study 198
Letter to Editor: Carpal tunnel syndrome due to an atypical deep soft tissue leiomyoma: The risk of misdiagnosis and mismanagement 195
Topiramate in the prevention of pediatric migraine: Literature review 195
Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine 194
Habituation to Pain in "Medication Overuse Headache": A CO2 Laser-Evoked Potential Study 193
Topiramate in migraine prophylaxis: A randomised double-blind versus placebo study 190
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study 189
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study 187
Left thalamomegaly in a patient with partial epilepsy 184
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: Acetylcholinesterase activity cannot be considered a useful biomarker 182
Evidence of different spinal pathways for the warmth evoked potentials 180
Multiple attack study on the available triptans in Italy versus placebo 180
Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study) 176
Detection of Neurofilament Light Chain with Label-Free Electrolyte-Gated Organic Field-Effect Transistors 176
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 172
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis 170
Kappa Index Versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders 167
Occupational head injury and subsequent glioma 163
Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients 159
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis 159
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy 159
Acute hemichorea as unusual first multiple sclerosis presentation: two case reports 159
Risk of secondary progressive multiple sclerosis: A longitudinal study 153
Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients 153
Treatment response score to glatiramer acetate or interferon beta-1a 153
Antiepileptic drugs in migraine prophylaxis: state of the art 151
Informing MS patients on treatment options: a consensus on the process of consent taking 148
A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis 148
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 146
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing–remitting multiple sclerosis 137
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 137
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 135
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 134
A novel SOD1 mutation in a young ALS patient associated with slowly progressive clinical course 126
Cell-based assays for the detection of MOG antibodies: a comparative study 125
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder 124
Association of Sustained Immunotherapy with Disability Outcomes in Patients with Active Secondary Progressive Multiple Sclerosis 124
Microglia activation: A role for mitochondrial DNA? 123
A study of the CD45 exon 4 C77G polymorphism in a patient affected both by multiple sclerosis and pulmonary Langerhans' cell histiocytosis 111
Modulation of tregs and inkt by fingolimod in multiple sclerosis patients 110
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 109
Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus 105
The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies 102
Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years 102
Early clinical markers of aggressive multiple sclerosis 101
Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score 101
Delay from treatment start to full effect of immunotherapies for multiple sclerosis 99
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 99
Totale 21.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.706 0 0 0 0 0 193 186 371 164 428 224 140
2021/20222.370 216 274 249 93 40 134 107 141 252 225 403 236
2022/20231.749 198 206 146 181 198 250 21 191 193 13 102 50
2023/20241.247 33 77 60 158 229 108 147 155 30 15 63 172
2024/20254.290 151 37 47 322 911 713 198 213 499 242 382 575
2025/20264.581 525 336 704 1.013 1.399 604 0 0 0 0 0 0
Totale 22.541